866-997-4948(US-Canada Toll Free)

Global Orphan Drugs Market Research Report 2017

Published By :

QYResearch

Published Date : Mar 2017

Category :

Pharmaceutical

No. of Pages : 115 Pages

In this report, the global Orphan Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Orphan Drugs in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
Global Orphan Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Bayer
Bristol-Myers Squibb
Novartis
Pfizer
Roche
Sanofi
Johnson & Johnson
Eli Lilly & Co.
Celgene
Biogen IDEC
Pharmacyclics
Vertex
Onyx
AstraZeneca
Baxter
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
New Molecular Entities Drugs
Biologics Drugs
Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Orphan Drugs for each application, including
Oncologic
Metabolic
Hematologic-Immunologic
Infections/Parasitic
Other

Table of Contents

Global Orphan Drugs Market Research Report 2017
1 Orphan Drugs Market Overview
1.1 Product Overview and Scope of Orphan Drugs
1.2 Orphan Drugs Segment by Type (Product Category)
1.2.1 Global Orphan Drugs Production and CAGR (%) Comparison by Type (Product Category) (2012-2022)
1.2.2 Global Orphan Drugs Production Market Share by Type (Product Category) in 2016
1.2.3 New Molecular Entities Drugs
1.2.4 Biologics Drugs
1.2.5 Other
1.3 Global Orphan Drugs Segment by Application
1.3.1 Orphan Drugs Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Oncologic
1.3.3 Metabolic
1.3.4 Hematologic-Immunologic
1.3.5 Infections/Parasitic
1.3.6 Other
1.4 Global Orphan Drugs Market by Region (2012-2022)
1.4.1 Global Orphan Drugs Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Orphan Drugs (2012-2022)
1.5.1 Global Orphan Drugs Revenue Status and Outlook (2012-2022)
1.5.2 Global Orphan Drugs Capacity, Production Status and Outlook (2012-2022)

2 Global Orphan Drugs Market Competition by Manufacturers
2.1 Global Orphan Drugs Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Orphan Drugs Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Orphan Drugs Production and Share by Manufacturers (2012-2017)
2.2 Global Orphan Drugs Revenue and Share by Manufacturers (2012-2017)
2.3 Global Orphan Drugs Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Orphan Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Orphan Drugs Market Competitive Situation and Trends
2.5.1 Orphan Drugs Market Concentration Rate
2.5.2 Orphan Drugs Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Orphan Drugs Capacity, Production, Revenue (Value) by Region (2012-2017)
3.1 Global Orphan Drugs Capacity and Market Share by Region (2012-2017)
3.2 Global Orphan Drugs Production and Market Share by Region (2012-2017)
3.3 Global Orphan Drugs Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Orphan Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Orphan Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Orphan Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Orphan Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Orphan Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Orphan Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Orphan Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Orphan Drugs Supply (Production), Consumption, Export, Import by Region (2012-2017)
4.1 Global Orphan Drugs Consumption by Region (2012-2017)
4.2 North America Orphan Drugs Production, Consumption, Export, Import (2012-2017)
4.3 Europe Orphan Drugs Production, Consumption, Export, Import (2012-2017)
4.4 China Orphan Drugs Production, Consumption, Export, Import (2012-2017)
4.5 Japan Orphan Drugs Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Orphan Drugs Production, Consumption, Export, Import (2012-2017)
4.7 India Orphan Drugs Production, Consumption, Export, Import (2012-2017)

5 Global Orphan Drugs Production, Revenue (Value), Price Trend by Type
5.1 Global Orphan Drugs Production and Market Share by Type (2012-2017)
5.2 Global Orphan Drugs Revenue and Market Share by Type (2012-2017)
5.3 Global Orphan Drugs Price by Type (2012-2017)
5.4 Global Orphan Drugs Production Growth by Type (2012-2017)

6 Global Orphan Drugs Market Analysis by Application
6.1 Global Orphan Drugs Consumption and Market Share by Application (2012-2017)
6.2 Global Orphan Drugs Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Orphan Drugs Manufacturers Profiles/Analysis
7.1 Bayer
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Orphan Drugs Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Bayer Orphan Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 Bristol-Myers Squibb
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Orphan Drugs Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Bristol-Myers Squibb Orphan Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business/Business Overview
7.3 Novartis
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Orphan Drugs Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Novartis Orphan Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Main Business/Business Overview
7.4 Pfizer
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Orphan Drugs Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Pfizer Orphan Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Main Business/Business Overview
7.5 Roche
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Orphan Drugs Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Roche Orphan Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Main Business/Business Overview
7.6 Sanofi
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Orphan Drugs Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Sanofi Orphan Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Main Business/Business Overview
7.7 Johnson & Johnson
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Orphan Drugs Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Johnson & Johnson Orphan Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Main Business/Business Overview
7.8 Eli Lilly & Co.
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Orphan Drugs Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Eli Lilly & Co. Orphan Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.8.4 Main Business/Business Overview
7.9 Celgene
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Orphan Drugs Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Celgene Orphan Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.9.4 Main Business/Business Overview
7.10 Biogen IDEC
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Orphan Drugs Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Biogen IDEC Orphan Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.10.4 Main Business/Business Overview
7.11 Pharmacyclics
7.12 Vertex
7.13 Onyx
7.14 AstraZeneca
7.15 Baxter

8 Orphan Drugs Manufacturing Cost Analysis
8.1 Orphan Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Orphan Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Orphan Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Orphan Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Orphan Drugs Market Forecast (2017-2022)
12.1 Global Orphan Drugs Capacity, Production, Revenue Forecast (2017-2022)
12.1.1 Global Orphan Drugs Capacity, Production and Growth Rate Forecast (2017-2022)
12.1.2 Global Orphan Drugs Revenue and Growth Rate Forecast (2017-2022)
12.1.3 Global Orphan Drugs Price and Trend Forecast (2017-2022)
12.2 Global Orphan Drugs Production, Consumption , Import and Export Forecast by Region (2017-2022)
12.2.1 North America Orphan Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.2 Europe Orphan Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.3 China Orphan Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.4 Japan Orphan Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.5 Southeast Asia Orphan Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.6 India Orphan Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Orphan Drugs Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Orphan Drugs Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer


List of Table

List of Tables and Figures

Figure Picture of Orphan Drugs
Figure Global Orphan Drugs Production (K MT) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Orphan Drugs Production Market Share by Types (Product Category) in 2016
Figure Product Picture of New Molecular Entities Drugs
Table Major Manufacturers of New Molecular Entities Drugs
Figure Product Picture of Biologics Drugs
Table Major Manufacturers of Biologics Drugs
Figure Product Picture of Other
Table Major Manufacturers of Other
Figure Global Orphan Drugs Consumption (K MT) by Applications (2012-2022)
Figure Global Orphan Drugs Consumption Market Share by Applications in 2016
Figure Oncologic Examples
Figure Metabolic Examples
Figure Hematologic-Immunologic Examples
Figure Infections/Parasitic Examples
Figure Other Examples
Figure Global Orphan Drugs Market Size (Million USD), Comparison (K MT) and CAGR (%) by Regions (2012-2022)
Figure North America Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Orphan Drugs Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Orphan Drugs Capacity, Production (K MT) Status and Outlook (2012-2022)
Figure Global Orphan Drugs Major Players Product Capacity (K MT) (2012-2017)
Table Global Orphan Drugs Capacity (K MT) of Key Manufacturers (2012-2017)
Table Global Orphan Drugs Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Orphan Drugs Capacity (K MT) of Key Manufacturers in 2016
Figure Global Orphan Drugs Capacity (K MT) of Key Manufacturers in 2017
Figure Global Orphan Drugs Major Players Product Production (K MT) (2012-2017)
Table Global Orphan Drugs Production (K MT) of Key Manufacturers (2012-2017)
Table Global Orphan Drugs Production Share by Manufacturers (2012-2017)
Figure 2016 Orphan Drugs Production Share by Manufacturers
Figure 2017 Orphan Drugs Production Share by Manufacturers
Figure Global Orphan Drugs Major Players Product Revenue (Million USD) (2012-2017)
Table Global Orphan Drugs Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Orphan Drugs Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Orphan Drugs Revenue Share by Manufacturers
Table 2017 Global Orphan Drugs Revenue Share by Manufacturers
Table Global Market Orphan Drugs Average Price (USD/MT) of Key Manufacturers (2012-2017)
Figure Global Market Orphan Drugs Average Price (USD/MT) of Key Manufacturers in 2016
Table Manufacturers Orphan Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Orphan Drugs Product Category
Figure Orphan Drugs Market Share of Top 3 Manufacturers
Figure Orphan Drugs Market Share of Top 5 Manufacturers
Table Global Orphan Drugs Capacity (K MT) by Region (2012-2017)
Figure Global Orphan Drugs Capacity Market Share by Region (2012-2017)
Figure Global Orphan Drugs Capacity Market Share by Region (2012-2017)
Figure 2016 Global Orphan Drugs Capacity Market Share by Region
Table Global Orphan Drugs Production by Region (2012-2017)
Figure Global Orphan Drugs Production (K MT) by Region (2012-2017)
Figure Global Orphan Drugs Production Market Share by Region (2012-2017)
Figure 2016 Global Orphan Drugs Production Market Share by Region
Table Global Orphan Drugs Revenue (Million USD) by Region (2012-2017)
Table Global Orphan Drugs Revenue Market Share by Region (2012-2017)
Figure Global Orphan Drugs Revenue Market Share by Region (2012-2017)
Table 2016 Global Orphan Drugs Revenue Market Share by Region
Figure Global Orphan Drugs Capacity, Production (K MT) and Growth Rate (2012-2017)
Table Global Orphan Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Table North America Orphan Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Table Europe Orphan Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Table China Orphan Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Table Japan Orphan Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Table Southeast Asia Orphan Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Table India Orphan Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Table Global Orphan Drugs Consumption (K MT) Market by Region (2012-2017)
Table Global Orphan Drugs Consumption Market Share by Region (2012-2017)
Figure Global Orphan Drugs Consumption Market Share by Region (2012-2017)
Figure 2016 Global Orphan Drugs Consumption (K MT) Market Share by Region
Table North America Orphan Drugs Production, Consumption, Import & Export (K MT) (2012-2017)
Table Europe Orphan Drugs Production, Consumption, Import & Export (K MT) (2012-2017)
Table China Orphan Drugs Production, Consumption, Import & Export (K MT) (2012-2017)
Table Japan Orphan Drugs Production, Consumption, Import & Export (K MT) (2012-2017)
Table Southeast Asia Orphan Drugs Production, Consumption, Import & Export (K MT) (2012-2017)
Table India Orphan Drugs Production, Consumption, Import & Export (K MT) (2012-2017)
Table Global Orphan Drugs Production (K MT) by Type (2012-2017)
Table Global Orphan Drugs Production Share by Type (2012-2017)
Figure Production Market Share of Orphan Drugs by Type (2012-2017)
Figure 2016 Production Market Share of Orphan Drugs by Type
Table Global Orphan Drugs Revenue (Million USD) by Type (2012-2017)
Table Global Orphan Drugs Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Orphan Drugs by Type (2012-2017)
Figure 2016 Revenue Market Share of Orphan Drugs by Type
Table Global Orphan Drugs Price (USD/MT) by Type (2012-2017)
Figure Global Orphan Drugs Production Growth by Type (2012-2017)
Table Global Orphan Drugs Consumption (K MT) by Application (2012-2017)
Table Global Orphan Drugs Consumption Market Share by Application (2012-2017)
Figure Global Orphan Drugs Consumption Market Share by Applications (2012-2017)
Figure Global Orphan Drugs Consumption Market Share by Application in 2016
Table Global Orphan Drugs Consumption Growth Rate by Application (2012-2017)
Figure Global Orphan Drugs Consumption Growth Rate by Application (2012-2017)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Orphan Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bayer Orphan Drugs Production Growth Rate (2012-2017)
Figure Bayer Orphan Drugs Production Market Share (2012-2017)
Figure Bayer Orphan Drugs Revenue Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Myers Squibb Orphan Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Orphan Drugs Production Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Orphan Drugs Production Market Share (2012-2017)
Figure Bristol-Myers Squibb Orphan Drugs Revenue Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Orphan Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novartis Orphan Drugs Production Growth Rate (2012-2017)
Figure Novartis Orphan Drugs Production Market Share (2012-2017)
Figure Novartis Orphan Drugs Revenue Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Orphan Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Orphan Drugs Production Growth Rate (2012-2017)
Figure Pfizer Orphan Drugs Production Market Share (2012-2017)
Figure Pfizer Orphan Drugs Revenue Market Share (2012-2017)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Orphan Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Roche Orphan Drugs Production Growth Rate (2012-2017)
Figure Roche Orphan Drugs Production Market Share (2012-2017)
Figure Roche Orphan Drugs Revenue Market Share (2012-2017)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Orphan Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sanofi Orphan Drugs Production Growth Rate (2012-2017)
Figure Sanofi Orphan Drugs Production Market Share (2012-2017)
Figure Sanofi Orphan Drugs Revenue Market Share (2012-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Orphan Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Johnson & Johnson Orphan Drugs Production Growth Rate (2012-2017)
Figure Johnson & Johnson Orphan Drugs Production Market Share (2012-2017)
Figure Johnson & Johnson Orphan Drugs Revenue Market Share (2012-2017)
Table Eli Lilly & Co. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly & Co. Orphan Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Eli Lilly & Co. Orphan Drugs Production Growth Rate (2012-2017)
Figure Eli Lilly & Co. Orphan Drugs Production Market Share (2012-2017)
Figure Eli Lilly & Co. Orphan Drugs Revenue Market Share (2012-2017)
Table Celgene Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celgene Orphan Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Celgene Orphan Drugs Production Growth Rate (2012-2017)
Figure Celgene Orphan Drugs Production Market Share (2012-2017)
Figure Celgene Orphan Drugs Revenue Market Share (2012-2017)
Table Biogen IDEC Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biogen IDEC Orphan Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Biogen IDEC Orphan Drugs Production Growth Rate (2012-2017)
Figure Biogen IDEC Orphan Drugs Production Market Share (2012-2017)
Figure Biogen IDEC Orphan Drugs Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Orphan Drugs
Figure Manufacturing Process Analysis of Orphan Drugs
Figure Orphan Drugs Industrial Chain Analysis
Table Raw Materials Sources of Orphan Drugs Major Manufacturers in 2016
Table Major Buyers of Orphan Drugs
Table Distributors/Traders List
Figure Global Orphan Drugs Capacity, Production (K MT) and Growth Rate Forecast (2017-2022)
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Orphan Drugs Price (Million USD) and Trend Forecast (2017-2022)
Table Global Orphan Drugs Production (K MT) Forecast by Region (2017-2022)
Figure Global Orphan Drugs Production Market Share Forecast by Region (2017-2022)
Table Global Orphan Drugs Consumption (K MT) Forecast by Region (2017-2022)
Figure Global Orphan Drugs Consumption Market Share Forecast by Region (2017-2022)
Figure North America Orphan Drugs Production (K MT) and Growth Rate Forecast (2017-2022)
Figure North America Orphan Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Orphan Drugs Production, Consumption, Export and Import (K MT) Forecast (2017-2022)
Figure Europe Orphan Drugs Production (K MT) and Growth Rate Forecast (2017-2022)
Figure Europe Orphan Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Orphan Drugs Production, Consumption, Export and Import (K MT) Forecast (2017-2022)
Figure China Orphan Drugs Production (K MT) and Growth Rate Forecast (2017-2022)
Figure China Orphan Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Orphan Drugs Production, Consumption, Export and Import (K MT) Forecast (2017-2022)
Figure Japan Orphan Drugs Production (K MT) and Growth Rate Forecast (2017-2022)
Figure Japan Orphan Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Orphan Drugs Production, Consumption, Export and Import (K MT) Forecast (2017-2022)
Figure Southeast Asia Orphan Drugs Production (K MT) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Orphan Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Orphan Drugs Production, Consumption, Export and Import (K MT) Forecast (2017-2022)
Figure India Orphan Drugs Production (K MT) and Growth Rate Forecast (2017-2022)
Figure India Orphan Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Orphan Drugs Production, Consumption, Export and Import (K MT) Forecast (2017-2022)
Table Global Orphan Drugs Production (K MT) Forecast by Type (2017-2022)
Figure Global Orphan Drugs Production (K MT) Forecast by Type (2017-2022)
Table Global Orphan Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Orphan Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Global Orphan Drugs Price Forecast by Type (2017-2022)
Table Global Orphan Drugs Consumption (K MT) Forecast by Application (2017-2022)
Figure Global Orphan Drugs Consumption (K MT) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *